These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 35150198)
1. Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway. Wang J; Quan Y; Lv J; Gong S; Ren P Environ Toxicol; 2022 Jun; 37(6):1343-1356. PubMed ID: 35150198 [TBL] [Abstract][Full Text] [Related]
2. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis. Li C; Yang J; Lei S; Wang W Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155 [TBL] [Abstract][Full Text] [Related]
3. LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/β-catenin signaling. Li C; Yang J; Wang W; Li R J Bioenerg Biomembr; 2021 Feb; 53(1):61-71. PubMed ID: 33394310 [TBL] [Abstract][Full Text] [Related]
4. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway. Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987 [TBL] [Abstract][Full Text] [Related]
5. Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling. Zhang J; Liu Y; Pu S; He J; Zhou C Breast Cancer Res Treat; 2021 Feb; 186(1):247-258. PubMed ID: 33423159 [TBL] [Abstract][Full Text] [Related]
6. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
7. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253 [TBL] [Abstract][Full Text] [Related]
8. METTL3 regulates FAM83D m Yu X; Li Y; Kong F; Xu Q Toxicol In Vitro; 2024 Mar; 95():105746. PubMed ID: 38043628 [TBL] [Abstract][Full Text] [Related]
9. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Tomar VS; Patil V; Somasundaram K Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290 [TBL] [Abstract][Full Text] [Related]
10. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression. Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577 [TBL] [Abstract][Full Text] [Related]
11. Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway. Hua YQ; Zhang K; Sheng J; Ning ZY; Li Y; Shi WD; Liu LM Life Sci; 2021 Dec; 287():119205. PubMed ID: 33571515 [TBL] [Abstract][Full Text] [Related]
12. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway. Zhu H; Diao S; Lim V; Hu L; Hu J Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187 [TBL] [Abstract][Full Text] [Related]
13. PHLDA3 exerts an antitumor function in prostate cancer by down-regulating Wnt/β-catenin pathway via inhibition of Akt. Ma S; Quan P; Yu C; Fan X; Yang S; Jia W; Zhang L; Wang F; Liu F; Yang L; Qin W; Yang X Biochem Biophys Res Commun; 2021 Sep; 571():66-73. PubMed ID: 34303965 [TBL] [Abstract][Full Text] [Related]
14. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma. Lan F; Pan Q; Yu H; Yue X J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372 [TBL] [Abstract][Full Text] [Related]
15. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling. Feng X; Jiang J; Sun L; Zhou Q Toxicol Appl Pharmacol; 2022 Apr; 440():115940. PubMed ID: 35219640 [TBL] [Abstract][Full Text] [Related]
16. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway. Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345 [TBL] [Abstract][Full Text] [Related]
17. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway. Wang M; Li C; Shi W Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248 [TBL] [Abstract][Full Text] [Related]
18. Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM. Li W; Miao X; Liu L; Zhang Y; Jin X; Luo X; Gao H; Deng X Oncotarget; 2017 Apr; 8(15):25167-25176. PubMed ID: 28445937 [TBL] [Abstract][Full Text] [Related]
19. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion. Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells via Suppression of Wnt/β-Catenin Pathway. Xu J; Su Z; Ding Q; Shen L; Nie X; Pan X; Yan A; Yan R; Zhou Y; Li L; Lu B Oncol Res; 2019 Jul; 27(7):819-826. PubMed ID: 30940290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]